| Value | ₹0.31 Cr |
|---|---|
| Execution period | 4 years |
NSE filing, NSE: AWFIS. Summary written from the filing by ALFA Finder's alert engine.
Awfis Space Solutions Ltd: key numbers
- Share price
- ₹239.66
- Market cap
- ₹1,715 Cr
- Revenue (annual)
- ₹1,493 Cr
- Net profit (annual)
- ₹70.85 Cr
- P/E (TTM)
- 20.2×Sector 34.1×
- Promoter holding
- 17.00%+0.00% QoQ
- FII holding
- 25.37%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Awfis Space Solutions Ltd
All →Awfis Space Solutions Capacity Expansion
Awfis launched ~1,45,000 sq. ft. of premium workspaces across Pune, Bengaluru, and Mumbai. The expansion deepens its Grade A+ footprint in key metro cities.
- chargeable workspace area
- 145000 sq. ft.
Awfis Space Solutions Board Meeting Date
Awfis Space Solutions has scheduled a Board Meeting for November 3, 2026. The Board will approve Q1 and H1 FY27 unaudited financial results.
Awfis Space Solutions Other Announcement
Awfis Space Solutions Ltd filed a Regulation 74(5) certificate from its RTA, confirming the non-applicability of the regulation as all shares are held in dematerialized form.
Awfis Space Solutions Legal & Regulatory
Awfis Space Solutions received an adverse arbitral award of ₹8.26 crore. The company anticipates a net incremental cost impact not exceeding ₹6.3 crore.
- Value
- ₹8.26 Cr
Awfis Space Solutions Debt & Borrowing: ₹80 Cr
Awfis Space Solutions has availed debt facilities totalling INR 80 Crore from IDFC FIRST Bank Limited, comprising an overdraft and a corporate term loan.
- Value
- ₹80.00 Cr
- From
- IDFC FIRST Bank Limited
Awfis Space Solutions Capacity Expansion
Awfis launched its 9th Elite centre in Aerocity, New Delhi, adding ~1,00,000 sq. ft. of premium workspace. This expands its premium portfolio to 37 centres across India.
- workspace area
- 100000 sq. ft.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date